Hong Kong biotech leader forging ahead with groundbreaking cancer therapies
PostMag talks to 5 women innovators at the top of their game and pushing the boundaries of scientific discovery: here we meet Gina Jiang, managing director of the Hong Kong Institute of Biotechnology

Gina Jiang took an unconventional route to the top. The daughter of an orthopaedic surgeon and an oil painter, the 44-year-old Taiwanese-Canadian has a degree in general medicine from Peking University but chose not to be a medical doctor or clinical researcher. Instead, Jiang has built a 20-plus-year career finding ways to make new therapies available to patients. She is the one who figures out what’s needed, who’s needed and what hurdles need to be overcome for treatments to go from the lab to hospital bedsides – otherwise known as translational medicine.

Cell therapy isn’t a miracle cure. It’s still ongoing and being studied, but the hope it brings and the visible improvements I’ve witnessed motivates me and makes me excited
Jiang has built several medical technology companies in Silicon Valley and Taipei, including FGMi Inc, which focuses on analysing patient needs to fast-track research into application. Design Thinking Foundry, a social enterprise she co-founded in 2017, puts patient experience at the centre of designing medical technology.
First sparks
